Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ghrelin Expression Could Regulate Diastolic Heart Function in Obese Patients With Diabetes

NCT05988346 is registered in ClinicalTrials.gov with University of Campania Luigi Vanvitelli as lead sponsor.

NCT NCT05988346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05988346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ghrelin Expression Could Regulate Diastolic Heart Function in Obese Patients With Diabetes
Lead sponsor
University of Campania Luigi Vanvitelli
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
March 1, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, diastolic dysfunction, obesity, abdominal